Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

ClinicalTrials.gov ID: NCT00245388

Public ClinicalTrials.gov record NCT00245388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 10:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Trial to Determine the Lipid-Lowering Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, dose-ranging, placebo-controlled trial to determine the lipid-lowering efficacy and safety of BMS-298585 (muraglitazar) alone in combination with pravastatin in subjects with mixed dyslipidemia.

Study identification

NCT ID
NCT00245388
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
330 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Not listed
Completion
Jul 2002 (Actual)
Last update posted
Apr 23, 2012

2002

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
53
Facility City State ZIP Site status
Local Institution Phoenix Arizona — —
Local Institution Little Rock Arkansas — —
Local Institution Irvine California — —
Local Institution Long Beach California — —
Local Institution Raleigh California — —
Local Institution Roseville California — —
Local Institution Sacramento California — —
Local Institution San Diego California — —
Local Institution Santa Ana California — —
Local Institution Longmont Colorado — —
Local Institution Clearwater Florida — —
Local Institution Cooper City Florida — —
Local Institution DeLand Florida — —
Local Institution Inverness Florida — —
Local Institution Longwood Florida — —
Local Institution Pembroke Pines Florida — —
Local Institution Sarasota Florida — —
Local Institution Stuart Florida — —
Local Institution Dunwoody Georgia — —
Local Institution Melbourne Georgia — —
Local Institution Peoria Illinois — —
Local Institution Indianapolis Indiana — —
Local Institution Iowa City Iowa — —
Local Institution Overland Park Kansas — —
Local Institution Wichita Kansas — —
Local Institution Louisville Kentucky — —
Local Institution Marrero Louisiana — —
Local Institution Baltimore Maryland — —
Local Institution Bethesda Maryland — —
Local Institution Edina Minnesota — —
Local Institution Minneapolis Minnesota — —
Local Institution Kansas City Missouri — —
Local Institution St Louis Missouri — —
Local Institution Toms River New Jersey — —
Local Institution Manlius New York — —
Local Institution Hickory North Carolina — —
Local Institution Winston-Salem North Carolina — —
Local Institution Columbus Ohio — —
Local Institution Bend Oregon — —
Local Institution Hillsboro Oregon — —
Local Institution Portland Oregon — —
Local Institution Philadelphia Pennsylvania — —
Local Institution Sellersville Pennsylvania — —
Local Institution Warminster Pennsylvania — —
Local Institution Greer South Carolina — —
Local Institution Mt. Pleasant South Carolina — —
Local Institution Austin Texas — —
Local Institution Dallas Texas — —
Local Institution San Angelo Texas — —
Local Institution San Antonio Texas — —
Local Institution Olympia Washington — —
Local Institution Seattle Washington — —
Local Institution Yakima Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00245388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2012 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00245388 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →